US 12215135
PDL2 compounds
granted A61KA61K38/00A61K39/39
Quick answer
US patent 12215135 (PDL2 compounds) held by IO Biotech ApS expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IO Biotech ApS
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61K39/39, A61K40/11, A61K40/421